Aadi Bioscience to Report First Quarter 2023 Results and Operational Update

Company to Host Conference Call and Webcast on Wednesday, May 10, 2023 LOS ANGELES, May 3, 2023 /PRNewswire/ — Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers…